[1]D'ANGELICA M I,JARNAGIN W RBLUMGART L H.Resectable hilar cholangiocarcinoma:surgical treatment and long-term outcome[J].Surg Today,2004,34(11):885-890.
[2]LILLEMOE K DCAMERON J L.Surgery for hilar cholangiocarcinoma:the Johns Hopkins approach[J].J Hepatobiliary Pancreat Surg,2000,7(2):115-121.
[3]TSAO J I,NIMURA Y,KAMIYA J,et al.Management of hilar cholangiocarcinoma:comparison of an American and a Japanese experience[J].Ann Surg,2000,232(2):166-174.
[4]KLATSKIN G.Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis.An unusual tumor with distinctive clinical and pathological features[J].Am J Med,1965,38:241-256.
[5]BISMUTH HCORLETTE M B.Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J].Surg Gynecol Obstet,1975,140(2):170-178.
[6]LAUNOIS B,CAMPION J P,BRISSOT P,et al.Carcinoma of the hepatic hilus.Surgical management and the case for resection[J].Ann Surg,1979,190(2):151-157.
[7]LAI E C,TOMPKINS R K,MANN L L,et al.Proximal bile duct cancer.Quality of survival[J].Ann Surg,1987,205(2):111-118.
[8]TSUZUKI T,OGATA Y,IIDA S,et al.Carcinoma of the bifurcation of the hepatic ducts[J].Arch Surg,1983,118(10):1147-1151.
[9]SUGIURA Y,NAKAMURA S,IIDA S,et al.Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction:a cooperative study of the Keio Bile Duct Cancer Study Group[J].Surgery,1994,115(4):445-451.
[10]KAWARADA Y,ISAJI S,TAOKA H,et al.S4a + S5 with caudate lobe(S1)resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract[J].J Gastrointest Surg,1999,3(4):369-373.
[11]KAWASAKI S,MAKUUCHI M,MIYAGAWA S,et al.Radical operation after portal embolization for tumor of hilar bile duct[J].J Am Coll Surg,1994,178(5):480-486.
[12]MIYAGAWA S,MAKUUCHI MKAWASAKI S.Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer[J].Arch Surg,1995,130(7):759-763.
[13]KAWASAKI S,IMAMURA H,KOBAYASHI A,et al.Results of surgical resection for patients with hilar bile duct cancer:application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization[J].Ann Surg,2003,238(1):84-92.
[14]SEYAMA Y,KUBOTA K,SANO K,et al.Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate[J].Ann Surg,2003,238(1):73-83.
[15]HEMMING A W,REED A I,FUJITA S,et al.Surgical management of hilar cholangiocarcinoma[J].Ann Surg,2005,241(5):693-699.
[16]KINOSHITA H,SAKAI K,HIROHASHI K,et al.Preoperative portal vein embolization for hepatocellular carcinoma[J].World J Surg,1986,10(5):803-808.
[17]IMAMURA H,SHIMADA R,KUBOTA M,et al.Preoperative portal vein embolization:an audit of 84 patients[J].Hepatology,1999,29(4):1099-1105.
[18]YAMAKADO K,TAKEDA K,NISHIDE Y,et al.Portal vein embolization with steel coils and absolute ethanol:a comparative experimental study with canine liver[J].Hepatology,1995,22(6):1812-1818.
[19]KANEKO T,NAKAO ATAKAGI H.Clinical studies of new material for portal vein embolization:comparison of embolic effect with different agents[J].Hepatogastroenterology,2002,49(44):472-477.
[20]KANEKO T,NAKAO ATAKAGI H.Experimental studies of new embolizing material for portal vein embolization[J].Hepatogastroenterology,2000,47(33):790-794.
[21]PARK S,YOON H K,LEE N,et al.Portal vein embolization with use of a new liquid embolic material:an experimental study[J].J Vasc Interv Radiol,1999,10(3):339-345.
[22]HEMMING A W,REED A I,HOWARD R J,et al.Preoperative portal vein embolization for extended hepatectomy[J].Ann Surg,2003,237(5):686-691.
[23]MADOFF D C,HICKS M E,ABDALLA E K,et al.Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy:safety and effectiveness-- study in 26 patients[J].Radiology,2003,227(1):251-260.
[24]KUBOTA K,MAKUUCHI M,KUSAKA K,et al.Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors[J].Hepatology,1997,26(5):1176-1181.
[25]易滨,姜小清.经皮肝门静脉栓塞在肝门部胆管癌根治性切除中的应用[J].肝胆外科杂志,2010,18(5):331-332.
[26]SHIMADA K,SANO T,SAKAMOTO Y,et al.Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma[J].World J Surg,2005,29(6):723-727.
[27]NAGINO M,KAMIYA J,ARAI T,et al.“Anatomic”right hepatic trisectionectomy(extended right hepatectomy)with caudate lobectomy for hilar cholangiocarcinoma[J].Ann Surg,2006,243(1):28-32.
[28]JIRTLE R L,CARR B ISCOTT C D.Modulation of insulin-like growth factor-Ⅱ/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration[J].J Biol Chem,1991,266(33):22444-22450.
[29]WADA K,NOMURA S,MORII E,et al.Changes in levels of mRNAs of transforming growth factor(TGF)-beta1,-beta2,-beta3,TGF-beta type Ⅱ receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium[J].J Steroid Biochem Mol Biol,1996,59(5/6):367-375.
[30]LEE K C,KINOSHITA H,HIROHASHI K,et al.Extension of surgical indications for hepatocellular carcinoma by portal vein embolization[J].World J Surg,1993,17(1):109-115.
[31]FUJII Y,SHIMADA H,ENDO I,et al.Changes in clinicopathological findings after portal vein embolization[J].Hepatogastroenterology,2000,47(36):1560-1563.
[32]FARGES O,BELGHITI J,KIANMANESH R,et al.Portal vein embolization before right hepatectomy:prospective clinical trial[J].Ann Surg,2003,237(2):208-217.